Your browser doesn't support javascript.
loading
Progression of Nigrostriatal Denervation in Cerebellar Multiple System Atrophy: A Prospective Study.
Wirth, Thomas; Namer, Izzie Jacques; Monga, Ben; Bund, Caroline; Iosif, Andra Valentina; Gebus, Odile; Montaut, Solveig; Bogdan, Thomas; Robelin, Laura; Renaud, Mathilde; Kremer, Stéphane; Tranchant, Christine; Anheim, Mathieu.
Afiliación
  • Wirth T; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Namer IJ; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Monga B; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Bund C; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Iosif AV; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Gebus O; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Montaut S; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Bogdan T; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Robelin L; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Renaud M; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Kremer S; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Tranchant C; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
  • Anheim M; From the Neurology Department (T.W., A.V.I., O.G., S.M., T.B., L.R., C.T., M.A.), Strasbourg University Hospital, Strasbourg, France; Strasbourg Federation of Translational Medicine (FMTS) (T.W., C.T., M.A.), Strasbourg University, Strasbourg, France; INSERM-U964 (T.W., C.T., M.A.), CNRS-UMR7104, Un
Neurology ; 98(6): 232-236, 2022 02 08.
Article en En | MEDLINE | ID: mdl-34880084
ABSTRACT

OBJECTIVES:

Nigrostriatal dopaminergic denervation (NSDD) remains poorly characterized in cerebellar multiple system atrophy (MSA-C). We aimed to study NSDD progression in MSA-C and evaluate the capacity for [123I]-FP-CIT-SPECT and parkinsonism to differentiate MSA-C from idiopathic late-onset cerebellar ataxia (ILOCA).

METHODS:

We included 85 patients successively referred for sporadic late-onset cerebellar ataxia (SLOCA). Every 6 months, SARA, UPDRS-III, and SDFS scores were measured, and MSA-C diagnostic criteria were searched for. Striatal/occipital dopaminergic binding ratio was evaluated every year with [123I]-FP-CIT-scintigraphy.

RESULTS:

After a mean follow-up of 33.8 months, 33 patients had probable MSA-C, 8 possible MSA-C, and 44 ILOCA. SARA and UPDRS-III scores worsened faster in the probable MSA-C group (p < 0.01) compared with the ILOCA group. The baseline striatal/occipital ratio was lower (2.3 vs 2.97; p < 0.01) and more decreasing among patients with probable MSA-C (p < 0.01). Weighting dysautonomia and parkinsonism and/or NSDD as additional and principal criterion, respectively, in the possible MSA-C diagnostic criteria slightly improved their specificity (81.6% vs 76.9%) and sensitivity (77.8% vs 72.2%) to predict a final diagnosis of probable MSA-C.

DISCUSSION:

Rapid symptom worsening and NSDD existence and progression predict MSA-C among patients with SLOCA. Parkinsonism, NSDD, and dysautonomia should be considered equivalent for possible MSA-C diagnosis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Degeneraciones Espinocerebelosas / Atrofia de Múltiples Sistemas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neurology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Degeneraciones Espinocerebelosas / Atrofia de Múltiples Sistemas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neurology Año: 2022 Tipo del documento: Article